Birchview Capital’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.8M	Buy	101,000 +70,000	+226%	+$1.25M	1.79%	16
2025 Q1	$552K	Hold	31,000	–	–	0.48%	31
2024 Q4	$924K	Buy	31,000 +11,000	+55%	+$328K	0.75%	24
2024 Q3	$313K	Hold	20,000	–	–	0.27%	44
2024 Q2	$343K	Buy	+20,000	New	+$343K	0.32%	41